| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 120,649 | 151,914 | 125,289 | | Cost of Revenue | 69,738 | 85,820 | 66,890 | | | Gross Profit | 50,912 | 66,094 | 58,399 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 54,299 | 61,111 | 45,602 | | Non Recurring | 293 |
-
|
-
| | Others | 9,628 | 9,898 | 14,132 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (13,309) | (4,915) | (1,335) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 702 | 4,061 | 3,285 | | Earnings Before Interest And Taxes | (11,370) | 3,692 | 3,565 | | Interest Expense | 3,193 | 1,448 | 129 | | Income Before Tax | (14,563) | 2,244 | 3,435 | | Income Tax Expense | 1,873 | 1,606 | (1,585) | | Minority Interest |
-
|
-
| (702) | | | | Net Income From Continuing Ops | (16,437) | 639 | 4,318 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (16,437) | 639 | 4,318 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($16,437) | $639 | $4,318 |
|
1.52% Nasdaq 0.00%
Income Statement
